Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry.
Wim A WuytsCaroline DahlqvistHans SlabbynckMarc SchlesserNatacha GusbinChristophe CompereSofie MaddensShemra RizzoKlaus-Uwe KirchgaesslerKaren BartleyBenjamin BonduePublished in: Pulmonary therapy (2022)
The PROOF registry provided valuable, real-world data on the association between baseline QoL and mortality, and longitudinal HCRU and QoL outcomes in patients with IPF over 24 months and identified that SGRQ may be an independent prognostic factor in IPF.